Ozempic and Mounjaro makers point to unexpected anti-aging effects
New data from pharmaceutical giants Novo Nordisk and Eli Lilly suggests that GLP-1 medications could slow down molecular aging clocks by several years.
Latest stories, in-depth analysis & breaking updates
New data from pharmaceutical giants Novo Nordisk and Eli Lilly suggests that GLP-1 medications could slow down molecular aging clocks by several years.
Researchers have sequenced the genome and epigenome of Jonathan the giant tortoise, uncovering genetic clues that could eventually inform human longevity research.